A Phase III, Multi-center, Open-label Trial to Investigate the Impact of a Treat, Counsel and Cure Strategy in Men Who Have Sex With Men With Hepatitis C Infection in the Swiss HIV Cohort Study
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms HCVree
- 09 Oct 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
- 09 Oct 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 11 Jul 2016 Status changed from not yet recruiting to recruiting.